RGT 2.90% 35.5¢ argent biopharma limited

Ann: MGC PHARMA 2021 CLINICAL TRIALS PROGRAM UPDATE, page-4

  1. 1,308 Posts.
    lightbulb Created with Sketch. 583
    https://hotcopper.com.au/data/attachments/3208/3208064-a540215928ae2a6b36abc798dbb5e7b7.jpg
    "Logistical issues surrounding obtaining bulk supply of a key ingredient"


    Well that bodes real well for being able to ramp up production to a meaningful level.

    Not only are they short on manufacturing capability but they can't even source bulk ingredients to even supoort a trial never mind the millions of doses they would like holdersto believethey will be selling.

    Laughable!
    Last edited by StockObserver: 25/05/21
 
watchlist Created with Sketch. Add RGT (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.